Transcript Highlights:

• Affairs, SB 3 by Perry relating to the regulation. of consumable hemp products and the hemp-derived cannabinoids

Transcript Highlights:

• that it would not prohibit or restrict the manufacture, distribution, or sale of hemp products or cannabinoid
• It does not treat hemp products as marijuana or a marijuana product, and so products that have cannabinoids
• And so products that have cannabinoids like CBD or CBG, CBN, or CBC, it means that those are not treated

Keywords: 1064, all

Transcript Highlights:

• references that statute, but there's probably specific language we want to use regarding cannabis and cannabinoids
• references that statute, but there's probably specific language we want to use regarding cannabis and cannabinoids

Keywords: 1183, house

Transcript Highlights:

• There are hundreds of cannabinoids, most of which are non-psychoactive, and contribute to a more balanced

Keywords: 995, all

Summary: The Special Joint Committee on Initiative Petitions held a public hearing on Initiative Petition 25-10, House Bill 5002, titled “An Act to Restore a Sensible Marijuana Policy,” which would repeal Massachusetts’ adult-use cannabis legalization framework. Chairs Brendan Crighton and Kate Hogan outlined the Article 48 initiative process and explained that the committee is gathering testimony for a report to the legislature. The hearing was organized into expert, proponent, opponent, and public testimony, with written testimony accepted through March 27. The first witness, Jessica Trow of MassBudget, testified in opposition to repeal and focused on cannabis-related revenue and social equity. She said legalization has generated nearly $2 billion statewide since adult-use sales began, with revenue flowing through the Marijuana Regulation Fund, the state sales tax, and local taxes and fees. She emphasized that funds support public health, the Cannabis Control Commission’s social equity work, the Cannabis Social Equity Fund, and municipal budgets, and argued that legalization has created pathways for communities harmed by prohibition. The petition’s spokesperson, Wendy Wakeman, argued in favor of repeal, saying legalization has worsened public health, safety, and quality of life, citing higher potency, addiction, youth use, impaired driving, workplace positives, and black-market concerns. Committee members questioned her about the data sources, the will of the voters, the role of paid signature gatherers, and the petition’s funding, including out-of-state and dark-money concerns. Opponents of the initiative then testified that repeal would harm a regulated industry that has created jobs, tax revenue, and social equity opportunities. Caroline Pino of STEM, Kristen Rogers of Levia, Judith Ledbetter of Project De-Stigmatized Healthcare, and Armani White of Firehouse Dispensary/EON described their businesses, community investments, and personal reliance on cannabis, and warned that repeal would push consumers back to the illicit market and undermine equity programs. In public testimony, Lucas Thayer of the Massachusetts Cannabis Reform Coalition and Jeff Rawson, a chemist and consumer protection advocate, also opposed the measure, arguing that regulated cannabis is safer than unregulated products and that repeal would damage investments and public safety. The hearing ended after the public testimony, and the committee voted to close the hearing.

Transcript Highlights:

• most important consumer safety information, like not for children, poison control information, cannabinoid
• control like not for children, poison control information,<00:02:26.240> uh<00:02:26.440> cannabinoid
• <00:02:27.680> content<00:02:28.240> and information, uh cannabinoid content and information
• , uh cannabinoid content and usage<00:02:28.959> instructions.

Keywords: 1187, senate, all

Transcript Highlights:

• It clarifies the regulation of lower-potency hemp-derived cannabinoid products.
• effectiveness of enforcement, consumer understanding, and adds clarity for enforcement of non-intoxicating cannabinoid
• The underlying bill itself, Senate File 2370, has to do with beverages, the low-potency cannabinoid beverages

Keywords: 1187, senate, all

Transcript Highlights:

• For different patients, different conditions, all have this system that interacts with cannabinoids.
• We make our own cannabinoids that interact with it, and everybody's endocannabinoid system is different
• in the activity of the systems that it affects, including but not exclusive to the endocrine and cannabinoid

Bills: HB46, HB35, HB4490, HB4454, HB2188, HB3078, HB4743, HB2556, HB46, HB5342, HB4783, HB3785, HB5278, HB1639, HB2581, HB4224, HB4070, HB4099, HB4882, HB3794

Keywords: local government spending cap, expenditure limit, political subdivision, property tax, ad valorem tax, budget cap, taxpayer protection, spending restraint, inflation adjustment, population growth, voter approval, supermajority vote, county budget, municipal budget, school district finance, junior college district, hospital district, special district, attorney general enforcement, local fiscal limits

Transcript Highlights:

• of prohibiting e-cigarette devices, including those that are contained in... ...mixed with any cannabinoids

Bills: SB2024, SB227, SB268, SB1467, SB1580, HB5537, SB1313, SB1677, SB918, SB331, SB2207, SB2721

Keywords: e-cigarettes, marketing prohibition, youth protection, criminal penalties, public health, school funding, education reform, state budget, property taxes, equity in education, health care, licensing, complaint procedure, disciplinary action, law enforcement, death records, vital statistics, healthcare, trauma facility, Medicaid

Transcript Highlights:

• But there's probably specific language we want to use regarding cannabis, cannabinoids, and hemp and

Transcript Highlights:

• strong, is that all therapeutic cannabis products are tested for contaminants and also for the cannabinoid
• profile, for the concentration, let's say, of THC, CBD, or other cannabinoids, and that is all labeled
• strong, is that all therapeutic cannabis products are tested for contaminants and also for the cannabinoid
• profile, for the concentration, let's say, of THC, CBD, or other cannabinoids, and that is all labeled
• profile, for the concentration, let's say, of THC, CBD, or other cannabinoids, and that is all labeled

Keywords: 1189, house, all

Transcript Highlights:

• The second is unlicensed intoxicating cannabinoids.
• In the time that I have left, I would like to briefly touch on intoxicating cannabinoids, which are frequently

Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.

Transcript Highlights:

• Law Enforcement, including OBNDD and AG, are really taking the lead on some of the hemp-derived cannabinoid

Keywords: 914, all

Transcript Highlights:

• publish commentaries on emerging evidence and a medical journal called the medical cannabis and cannabinoids

Bills: SB 10, SB 8, SB 15, SB 12, SB 6, SB 13, SB 9, SB 7, SB 17, SB 4, SB10, SB8, SB15, SB12, SB6, SB13, SB9, SB7, SB17, SB4

Keywords: sex designation, restroom access, civil penalties, private civil right of action, women's privacy, law enforcement, department file, employee records, misconduct, confidentiality, Texas occupations code, election laws, attorney general, prosecution, criminal offenses, criminal prosecution, jurisdiction, hemp, consumable hemp, hemp-derived cannabinoids

Transcript Highlights:

• The first is the hemp-derived cannabinoid program, regulated under Section 151.72.
• The first is the hemp-derived cannabinoid program, regulated under Section 151.72.
• The first is the hemp-derived cannabinoid program, regulated under Section 151.72.
• We have over 3,000, 4,000 registrants in the hemp-derived cannabinoid program, and we have about 10 inspectors

Keywords: 1187, senate, all

Transcript Highlights:

• we're seeing, anxiety, psychosis. ...which we're seeing, anxiety, psychosis, schizophrenia, and cannabinoid

Keywords: 995, all

Summary: The Joint Committee on Cannabis held a hearing on a package of cannabis bills focused on equity funding, delivery expansion, advertising restrictions, medical use, first responders, and ownership limits. Testimony strongly supported S. 87/H. 184 to direct a larger share of cannabis revenue into the Cannabis Social Equity Trust Fund and related equity programs, with speakers arguing the current funding is insufficient and that automatic transfers would better support businesses and communities harmed by the war on drugs. Several witnesses also backed H. 145/S. 89 to allow licensed cannabis delivery into municipalities that ban retail sales and to hotels, saying current rules unfairly limit social equity delivery operators and consumer access. There was also support for H. 176 on medical cannabis eligibility and S. 76 on cannabis use by first responders, while H. 177/H. 178 on new taxes drew opposition from several business owners who said the industry is already heavily burdened and overtaxed. A major point of debate was S. 94/H. 157, which would prohibit billboard advertising for non-prescription marijuana. Public health advocates, parents, and neuroscientists argued that cannabis billboards normalize use, are seen by youth, and are difficult to regulate effectively under the current 85% adult-audience standard. They urged a public health approach similar to tobacco restrictions. In contrast, several industry witnesses opposed further advertising limits, saying cannabis businesses already face strict marketing rules, billboards are privately owned, and additional restrictions would hurt small operators and raise First Amendment concerns. Some witnesses also criticized the proposed increase in ownership caps and consolidation provisions in the broader cannabis bill, warning they would favor large multistate companies over small and social equity businesses. Committee members asked questions about billboard ownership, enforcement of the current advertising rules, and the legal basis for restricting sign content. Witnesses and members also discussed the Cannabis Control Commission’s role, the difficulty of enforcing audience-composition standards, and whether delivery should be treated more like alcohol. No votes were taken during the hearing, and the chair noted that written testimony would continue to be accepted.

Transcript Highlights:

• Agriculture and Biosecurity that includes comprehensive licensing, education, and support for non-cannabinoid

Bills: SB2178

Keywords: industrial hemp, Hawaii, agriculture, sustainability, Native Hawaiian practices, regulation, cultural stewardship, economic development, 912, senate, all

Summary: The committee heard testimony on SP 2178, which would create an industrial hemp program in the Department of Agriculture and Biosecurity, establish an advisory board, support research through the University of Hawaii, and promote hemp-based materials and partnerships with Native Hawaiian practitioners and cooperatives. Testimony was generally supportive from industry, Native Hawaiian advocates, the Hawaii Farm Bureau, and the department, with supporters emphasizing economic opportunity, community-based development, and potential uses such as hempcrete and fiber products. The Department of Agriculture and Biosecurity also said it supported the intent, but its representative explained that the bill would require additional staffing and resources for education, monitoring, testing, and enforcement. Members raised concerns about overlapping regulation with USDA hemp licensing and the cost of new positions; the department estimated three additional positions at about $80,000 each and noted current federal licensing does not charge fees. The committee recommended passage with amendments, including removing state licensing requirements to avoid duplication with USDA authority, making technical changes, and blanking the appropriation amount for later consideration, and the recommendation was adopted unanimously. The committee also heard and later took action on several other measures. SB 2702, relating to Hawaiian Homes and an irrigation system inventory, drew support but was postponed for decision-making until February 5 so additional amendments could be prepared. SB 2785, relating to economic development, received mixed testimony but was recommended and adopted for passage without amendments. SB 2790, relating to the Department of Hawaiian Home Lands and the Mākai irrigation system, received strong support and was also passed unamended. SB 2314, relating to the Hawaiian language and the legal effect of Hawaiian versions of laws, drew support from the Hawaii Civil Rights Commission and others, while the Attorney General’s office raised concerns about the wording; the committee adopted amendments incorporating language from the judiciary, clarifying that English and Hawaiian are official languages and that priority goes to the version consistent with legislative intent when there is a material difference, and then passed the bill with amendments. All final votes reported were in favor, with no recorded opposition.

Transcript Highlights:

• And please consider banning the Delta 8 THC products and other synthetically derived cannabinoids from

Keywords: 999, senate, all

Transcript Highlights:

• And then a smaller grant to look at the effects of a minor cannabinoid compound.
• So, a non-psychoactive cannabinoid on pain outcomes, anti-nausea, and abuse potential. um change abuse
• host of data with our analytical chemistry collaborators testing over-the-counter products for cannabinoid

Keywords: 958, all

Summary: The committee met and approved the minutes from its August 27 meeting. It then received a presentation from Katherine Castanza of the National Conference of State Legislators on the Medicaid provisions in the 2025 budget reconciliation bill, referred to as HR1. She explained that the bill is estimated by CBO to save the federal government $911 billion over 10 years, with more than 20 Medicaid-specific provisions, most of the savings concentrated in five policies and largely backloaded into 2030-2034. She emphasized that the bill’s effects will vary by state, but that expansion states and hospitals are expected to be most affected, in part because of changes to eligibility, provider taxes, and state-directed payments. Castanza highlighted several new funding and flexibility provisions, including a $50 billion Rural Health Transformation Fund for 2026-2030 and a new home- and community-based services waiver option effective July 1, 2028, with $100 million in grants in fiscal year 2027. She also outlined major eligibility changes for Medicaid expansion adults: work or community engagement requirements effective January 1, 2027; twice-yearly redeterminations for the expansion population effective the same date; and new cost sharing for certain expansion adults effective October 1, 2028. She noted that Kentucky, as an expansion state, would be subject to these changes and that state agencies would face significant implementation demands, especially because federal guidance and timelines are tight. A substantial portion of the presentation focused on financing changes. Castanza described new limits on provider taxes, including a 0% safe harbor for new taxes and a phased reduction for existing taxes in expansion states beginning in 2028, while nursing facilities and intermediate care facilities are exempt from the reduction if already taxed. She also explained that state-directed payments will be capped and phased down over time, with existing arrangements grandfathered only briefly; she said Kentucky has 11 approved state-directed payments and could see significant fiscal effects. She added that the bill also bars Medicaid payments to Planned Parenthood or similarly situated providers for one year, changes immigrant eligibility rules effective October 1, 2026, lowers the federal match for certain emergency services, and expands the scope of the federal erroneous payment recoupment provision effective October 1, 2029. Throughout, she stressed that federal savings may translate into state cost shifts and that implementation timing will be critical.

Transcript Highlights:

• This very simply bans the hemp derived cannabinoid products that contains more than 0.4% milligrams of
• 04.040> derived This very simply bans the hemp derived This very simply bans the hemp derived cannabinoid
• products<02:42:05.560> that<02:42:05.720> contains<02:42:06.200> more cannabinoid
• products that contains more cannabinoid products that contains more than<02:42:06.520> 0.4%<02
• Um A member asked, “Explain to me like I'm 5 years old the difference between synthetic cannabinoid

Keywords: 1189, house, all